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ARTICLE
Attitudes of general practitioners and midwives
towards ethnicity-based haemoglobinopathy-
carrier screening
Suze MPJ Jans*,1,3, Ank de Jonge2, Lidewij Henneman1,4, Martina C Cornel1 and
Antoinette LM Lagro-Janssen3
Haemoglobinopathies (HbP) are severe autosomal recessive disorders with high prevalence among certain ethnic groups.
World Health Organisation (WHO) advises implementing screening programmes for risk groups. Research in the Netherlands
has shown that general practitioners and midwives do not perceive ethnicity as a risk factor for HbP. Moreover, registration of
ethnicity is a controversial societal issue, which may complicate the introduction of a national preconception or antenatal
carrier screening programme. This study investigates attitudes, intention and behaviour of general practitioners and midwives
towards ethnicity-based HbP-carrier screening in general. A structured questionnaire based on the Theory of Planned Behaviour
was sent by mail to a random selection of 2100 general practitioners and 1800 primary care midwives. Response was 35%
(midwives 44.2%; GPs 27.6%). Although 45% of respondents thought that offering a carrier test on the basis of ethnicity
alone should become national policy, it is currently not carried out. The main factor explaining lack of intention towards
ethnicity-based HbP-carrier screening was subjective norm, the perception that their peers do not think they should offer
screening (52.2% variance explained). If ethnicity-based HbP-carrier screening would become national policy, most
professionals report that they would carry this out. Most respondents favoured ethnicity registration for health purposes.
As most practitioners look for role models among peers, debate among general practitioners and midwives should be
encouraged when new policy is to be developed, articulating the voices of colleagues who already actively offer HbP-carrier
screening. Moreover, primary care professionals and professional organisations need support of policy at national level.
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INTRODUCTION
Haemoglobinopathies (HbP) such as sickle cell disease (SCD) and
thalassaemia are autosomal recessive disorders with severe anaemia,
variable but life-long morbidity and currently with a shortened
lifespan due to multi-organ ischaemic damage.1–3 Couples in which
both partners are carriers of HbP have an one-in-four chance in
each pregnancy of giving birth to an affected child. HbP is one of the
world’s main genetic disorders but occur more frequently in current
or formerly malaria-endemic areas, such as Africa, the Mediterranean
region, the Middle East and South-East Asia. Owing to immigration,
these disorders are now also common in non-endemic countries3 with
an estimated prevalence ranging from 5 to 40% depending
on ancestry.4 The prevalence of a positive carrier status of HbP in
the Netherlands has been estimated at 4–14% depending on ethnic
background5 with a birth prevalence of severe HbP of about
60 infants among 182 000 total births.6
In 2006, the World Health Organisation (WHO) urged member
states to increase the awareness of SCD and to develop services that
integrate carrier detection and genetic counselling within existing
primary healthcare systems, in addition to the services of specialists
such as clinical geneticists and paediatricians.4,7 Such genetic
population screening programmes have several social, ethical and
technological issues, which may vary according to the type of
screening. Universal neonatal screening as offered in the public
health setting generally serves the purpose of timely detection of a
disorder to prevent further illness. Ethical concerns centre primarily
on objections to abortion, embryo selection, and concerns on
eugenics and medicalisation of care, and are especially relevant in
the context of prenatal and preconceptional genetic screening, where
prevention is not the primary purpose. In the preconceptional
or prenatal setting, the primary aim of any genetic disorder-
related screening programme is a reproductive choice.8 Although
preconception carrier screening provides prospective parents with the
most reproductive choice, antenatal carrier screening has practical
advantages: it reaches the target population more easily. This article is
limited to preconception and antenatal HbP-carrier screening.
Although (ethnic) diversity and heterogeneous distribution of
HbP may make the introduction of such a programme challenging,
it is currently thought to be possible to develop an appro-
priate programme that meets the ethical considerations for the
introduction of genetic screening programmes as agreed upon at
European level.9
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England is an example of a country where a linked antenatal carrier
screening (both targeted and universal, depending on prevalence) and
neonatal screening programme (universal) for HbP is available.10 This
policy is supported by the National Institute for Health and Clinical
Excellence (NICE), which recommends (preconception) counselling
and carrier testing.11 Carriers can be identified by a simple and
inexpensive blood test (Hb-electrophoresis or high performance
liquid chromatography (HPLC)), allowing couples preferably before
pregnancy to be informed about their risk, giving them a wider scope
of reproductive options.
Although universal carrier screening, in which all women regardless
of their ethnicity who are either pregnant or planning to become
pregnant are offered carrier screening, may be preferable in equitable
terms, this may not always be preferred in economic terms because in
some geographical areas prevalence may be too low to warrant
universal screening even though this means some cases may be
missed.12 Even if universal screening would be the goal, women
should always be offered the choice to opt out. Information on risk
based on her ethnic background can be used to support women,
making an informed choice about whether to accept screening or not.
For example, targeted ethnicity-based screening as advised by the
American College of Obstetricians and Gynecologists (ACOG) may be
more appropriate.13 This requires health professionals, such as GPs
and midwives, to identify couples at risk by taking an ethnicity-related
history by asking them about their ancestry in conjunction with
offering them information about HbP-carrier screening when women
(and their partners) enter into care. Initiatives have been undertaken
to develop instruments to help decide who is eligible for testing and
who is not.10,14,15 Although implemented in England, this still awaits
further discussion in the Netherlands.
Pregnant women are mostly cared for in primary care by midwives
and occasionally by GPs and are currently at best offered carrier
testing on the basis of anaemia, a positive family history or at the
personal discretion of midwives and GPs in the Netherlands.16–18
However, if (primary) healthcare services want to adequately meet the
needs of the whole population, health professionals should be aware
of the specific healthcare requirements of certain ethnic groups.
In the past and even still today, ancestry or ethnicity-based
HbP screening has not been without controversy.19–21 A recent
study showed ethnic registration to be a controversial issue in the
Netherlands because of its relationship with the Second World War
and lingering feelings of guilt in Dutch society, causing it to be a
barrier for the introduction of HbP-carrier screening.22 Moreover, in a
pilot study, primary care professionals expressed that although they
support HbP-carrier screening, they do not interpret ethnicity as a
risk marker for HbP.23 In order to offer equitable health services to all
groups in society, health professionals need to be aware of ethnicity-
related health needs without the fear of raising issues of
discrimination or stigmatisation. As attitudes of health professionals
may influence clinical practice, the specific attitudes of such
professionals towards ethnic registration are of interest.
The aim of this study was to investigate the attitude, intention and
behaviour of midwives and GPs towards ethnic registration and their
willingness to undertake carrier testing for clients and patients on the
basis of ethnicity.
MATERIALS AND METHODS
Questionnaire
A cross sectional study was designed by means of a structured questionnaire
based on a previous pilot study23 including direct measures of the main
constructs of the Theory of Planned Behaviour (TPB; Figure 1). TPB interprets
the behavioural intentions concerning performance as the most immediate and
important predictor of whether people perform a certain behaviour.24
The behaviour of interest in this study was offering patients a HbP-carrier
test on the basis of their ethnicity, which was explained to participants in the
introduction to the questionnaire. We underlined the fact that the amount of
patients at risk in their practice and whether or not they tested them
for (carrier status of) HbP at present was irrelevant to being able to answer
the questions.
The relationship between attitudes, subjective norm and perceived
behavioural control is described by the theory as the underlying foundational
belief about the intention of performing the behaviour.
Attitude was measured by using multiple word pairs to answer two
questions. First, what do you think about offering your patients a carrier test
for HbP solely on the basis of ethnicity (regardless of family history)? A sum-score
was then calculated from answers scored on a 7-point scale using the following
word pairs: bad–good, nonsense–important, tough–easy, undesirable–
desirable, harmful–beneficial and discriminating–privilege. The results showed
good consistency for the total score (Cronbach’s alpha 0.86). The one factor
model fitted well using exploratory factor analysis, all items loaded onto one
factor.
Second, what do you think about registering the ethnicity of your patients? A
sum-score was calculated from answers scored on a 7-point scale using the
following word pairs: wrong–good, harmful–beneficial, nonsense–appropriate,
awkward–useful, discriminating–harmless and objectionable–desirable.
(Cronbach’s alpha 0.89). All items were loaded on one factor using exploratory
factor analysis.
Subsequent questions were answered with single word pairs. The question,
Do you think your colleagues believe a carrier test solely on the basis of ethnicity
should be offered to patients (certainly not (1)–certainly (7))? measured the
subjective norm of the professional groups. Behavioural control was measured
with the following question: Are you currently able to offer your patients a
carrier test for HbP on the basis of ethnicity alone (certainly not (1)certainly
(7))?
Two questions measured intention: Do you intend to offer your patients a
carrier test for HbP exclusively on the basis of ethnicity in the future (certainly not
(1)certainly (7))? and Do you intend to offer your patients a HbP-carrier test
solely on the basis of ethnicity, should this become a national policy (certainly not
(1)–certainly (7))?
Behaviour was measured by asking the following questions: Do you at
present offer your patients a HbP-carrier test solely on the basis of ethnicity (never
(1)–always (7))? and Do you offer your patients with unresolved anaemia and no
familial history a HbP-carrier test (never (1)–always (7))?
Responders were also asked if they thought that: A HbP-carrier test on the
basis of ethnicity alone should become national policy (binary answer: yes (1) or
no (2)). Finally, they were asked some basic characteristics (location of
practice, estimated percentage of population from the group at risk in their
practice and work experience).
Attitude 
Subjective
Norm  
Perceived
Behavioural
 control
Intention Behaviour 
Figure 1 Theory of Planned Behaviour.23
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The final version of the questionnaire was approved by members of an
expert group that consisted of members of the GP and midwifery professions,
a representative from the national patient organisation and researchers in the
field of HbP.
Respondents
The questionnaire was accompanied by a letter of introduction explaining the
aim of the project, that is, exploring the opinion of health care professionals
about offering patients a HbP-carrier test on the basis of their ethnicity and
underlining the fact that no specific knowledge about HbP was necessary to be
able to answer the questions. This was sent by post to 2100 GPs and 1800
primary care midwives between November and December 2009. GPs were
randomly selected from the total population of GPs (roughly 8000) by the
Netherlands Institute of Health Services Research (NIVEL). The total number
of midwives is small in the Netherlands; therefore, all primary care midwives
were sent a questionnaire. No reminders were sent out and no incentives were
offered to participate in the study.
Analysis
Differences between GPs and midwives were assessed by a two-tailed t-test
and w2: P-valueso0.05 are reported as statistically significant. Direct measures
of the main constructs of the TPB (attitude, subjective norm, perceived
behavioural control and intention) are reported as a mean. Standard linear
regression analysis was applied analysing data obtained according to the TPB
in order to explain the behaviour of midwives and GPs towards ethnicity-based
HbP-carrier testing (Figure 1). Variables were added backwards. Two tailed
values for Pearson’s correlations are reported between determinants from the
TPB. All data were analysed in SPSS 15.01 for Windows (SPSS Inc., Chicago,
IL, USA).
RESULTS
The questionnaire was returned by 1346 primary health care workers:
795 midwives (response rate 44.2%) and 551 GPs (response rate
27.6%) resulting in a total response rate of 35%.
Respondent characteristics are presented in Table 1. About half of
the respondents worked in urban areas. The average working
experience was 14 years. More midwives came from urban areas
compared to the GPs and they had a significantly longer working
experience. The estimated percentage of patients from ethnic mino-
rities in the practices showed a wide distribution of 0–95% with a
mean of 16.6% (SD 18.7%). The midwives reported significantly
higher estimates of clients from the groups at risk for HbP in their
practices.
Results according to items of the TPB are shown in Table 2.
Attitude
On average primary care providers have a fairly positive attitude
towards offering a test solely on the basis of ethnicity and regardless of
family history, midwives being more positive than GPs. The midwives
also displayed a more positive attitude towards the registration
of ethnicity.
Subjective norm
Both GPs and midwives were less positive about what they thought
their colleagues opinions were towards testing on the basis
of ethnicity. Most of them thought their colleagues would not
recommend screening based on ethnicity.
Perceived behavioural control
Although in practice the laboratory test is easily available, the
responses were close to the scale average. GPs felt somewhat more
able to actually carry out a HbP-carrier test compared with midwives.
Intention
GPs scored the intention of offering a HbP-carrier test to their
patients on the basis of ethnicity alone, more negative compared with
midwives, who scored almost neutral. However, if this were to
become national policy, most participants did express the intention
to offer this to their patients: midwives significantly more so
than GPs.
Current test behaviour
The scores for the questions on current behaviour showed that both
GPs and midwives almost never offer a carrier test for HbP on the
basis of ethnicity alone (mean scores 1.9 and 1.8). On the other hand,
specifically midwives were prepared to test patients on the basis
of unexplained anaemia as instructed by the guidelines of their
professional organisations (mean score 5.2). GPs, however, were less
inclined to do so (mean score 4.2); the difference was significant.
Of all primary care providers, 45% thought that offering a test for
carrier status on the basis of ethnicity alone should become national
policy, GPs thought so significantly less often than midwives.
Explaining intention and behaviour
For both midwives and GPs together, the intention of offering patients
a HbP-carrier test on the basis of ethnicity alone was largely explained
by three factors: the attitude towards offering patients a carrier test for
HbP only on the basis of ethnicity, subjective norm and control over
the ability to effectuate the test. This model explained 52.2% of the
variance (Po0.001). The subjective norm, that is, what GPs and
midwives perceived their colleagues’ opinion to be, contributed most
to the model (b¼ 0.49 Po0.001).
Variance changed only slightly by adding attitude towards the
registration of ethnicity to the model (explained variance 52.5%
Po0.001). In this model, attitude towards the registration of ethnicity
Table 1 Characteristics of respondents
GPs, N¼551 Midwives, N¼795
Urban location of practice, n (%)a 255 (46.4)c 452 (56.9)
Estimated average percentage of patients
from population at risk in practicea
12.9c 19.1
Years of experience (mean±SD)b 11.3 (9.0)c 17.3 (9.3)
Abbreviation: GP, general practitioner. aw2 test. bIndependent t-test. cDifference between groups
significant at Po0.001.
Table 2 Constructs of TPB, comparison between GPs and midwives
GPs mean
score (SD)
Midwives mean
score (SD)
Attitude towards testing on the basis of ethnicity 4.6a (1.3) 4.9 (1.3)
Attitude towards the registration of ethnicity
in daily practice
4.5a (1.4) 5.6 (1.2)
Subjective norm 3.6 (1.4) 3.8 (1.7)
Perceived behavioural control 4.4a (2.1) 4.0 (2.1)
Intention on the basis of ethnicity 3.4a (1.7) 3.9 (1.7)
Intention on the basis of national policy 5.1a (1.8) 5.7 (1.7)
Current behaviour 1.9 (1.4) 1.8 (1.6)
Current behaviour on basis of guidelines 4.2a (2.1) 5.2 (2.1)
Abbreviation: GP, general practitioner; TBP, Theory of planned behaviour. at-test, two tailed
significant Po0.001.
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was the second most important contributor (b¼ 0.31 Po0.001).
Characteristics of the participants, such as percentage of population
from the group at risk in their practice, work experience and location
of practice, did not influence intention towards screening for carrier
status of HbP on the basis of ethnicity.
DISCUSSION
Although at present midwives and GPs in the Netherlands do not
carry out HbP-carrier testing solely on the basis of their patient’s
ethnic background, they generally have a positive attitude towards
ethnicity-based carrier screening. This finding is supported by the
results of other studies.23,25 According to the TPB, subjective norm
influences intention and behaviour. As health care professionals
apparently only have very few examples of colleagues who carry out
this type of testing, they are not inclined to do so in their own
practice environment. However, they are prepared to follow guidance
should carrier screening become national policy. Control over the
ability to administer the test was also part of the model that explained
intention and behaviour. Midwives especially seemed less than secure
in their capability of carrying out a test for HbP-carrier status as they
scored significantly lower on this item (personal control) when
compared to GPs. Although ordering a HbP-carrier test is relatively
simple, the interpretation of the results is not always straight forward.
This requires more knowledge than health professionals may have26,27
and may explain why health professionals are reluctant in offering
carrier testing for HbP. Another reason may be that health
professionals incorrectly believe they are legally restricted to offer
carrier screening because of the Dutch Population Act.28
Interestingly, the attitude of midwives towards the registration of
ethnicity in daily practice was much more positive when compared
with GPs. One explanation may be that midwives are already used to
registering the ethnicity of their clients and in contrast to GPs also
have the possibility to do so in the software they use. It is unclear in
which manner midwives (and GPs) determine ethnicity; if and what
questions are asked or whether this is self reported or otherwise
determined. This important and interesting point needs further
investigation in the future.
As we wanted to know what health professionals thought in general
about ethnicity-related HbP screening, we did not specify when the
screening should take place; either preconceptionally or antenatally. It
is not inconceivable that attitudes may differ between the two as
reproductive options during the antenatal period are limited for a
carrier couple. The questionnaire was used in a previous pilot
project23 and discussed in the expert group. Despite this the
question A HbP-carrier test on the basis of ethnicity alone should
become national policy could be interpreted in several ways and is
therefore one of the limitations of the study. It is difficult to attribute
definitive meanings to the answers with this question: A person who
answers ‘no’ might do so either because he/she believes that screening
should only be offered if universal or because they do not believe such
screening for HbP should be offered at all in the Netherlands or that it
should be an individual decision at professional level. This needs
further study.
Although the response rate was low in this study (35%); it was
reached without sending out reminders and the response rate among
GPs was much lower resulting in a lower overall response rate. We
expected to receive more questionnaires from those GPs and
midwives practicing in urban areas with a higher percentage of the
population at risk. This was not the case, especially in the group of
GPs. The spread of practice location, however, corresponds with
national spread of GPs, indicating a representative sample.29
Responding GPs estimated only slightly more patients from ethnic
minorities in their practice (12.9%) compared with the national
population (11.2% non-western). In 2008, 19.6% of women in Dutch
midwifery practices were of non-Dutch ethnicity, which is
comparable to what the midwives in the study estimated.30 Other
surveys have encountered similar problems in terms of response and
indicated that a high workload prevented health professionals from
participating.31 A lack of interest or failure to see the importance of
the subject and the popularity of GPs as research objects may also
have influenced the lack of enthusiasm among GPs in returning the
questionnaire. Although the response rate was low, there was no
evidence of selection bias.
Achterberg et al32 argued that effective implementation of screening
for HbP will require changes at both regime (suppliers and users) and
landscape level (institutions, material social, political and legal
infrastructure), but that such change is difficult to achieve without
an active orchestrating role of the government. This contradicts
present governmental policy that expects the field of health
professionals to initiate such policies. The fact that similar
programmes in the Netherlands have been initiated by the
government in the past33 makes this all the more curious. Whether
or not to test for (carrier status of) HbP during reproductive life
(ie, preconceptional, antenatal or neonatal) has been debated since the
seventies and eighties. Possibly, previous sensitivities surrounding
ethnicity and ethnic registration are still applicable today.22
As most women in the Netherlands are cared for by midwives when
pregnant30 and most women will probably meet with their GP at
some point during their reproductive life, they would be the
professionals of choice to offer HbP-carrier screening to women
and/or couples.
Morgan et al34 showed that fewer than 28% of gynaecologists
offered their pregnant patients screening for cystic fibrosis, on the
basis of all of the criteria in the guidelines of the ACOG. One
explanation given was that almost 60% did not feel familiar enough
with genetics to offer screening.35 This lack of knowledge displays a
need for continuing education in genetics, a problem which probably
also exists among primary healthcare professionals. Vansenne et al26
reported a lack of HbP knowledge and clinical experience influencing
primary care practitioners’ behaviour in neonatal screening, which
confirms the need for further education.
Besides knowledge development, the use of specific antenatal
laboratory forms (such as used for the Antenatal Screening
Programme for Infectious Diseases and Pregnancy Immunisation,
PSIE, programme36) could prompt health professionals to initiate
HbP-carrier testing and may encourage implementation of testing.
As the design of this form is not the responsibility of professional
organisations, such as those of GPs and midwives, it would still
require some form of governmental or laboratory experts’ initiative.
It has been shown that informed choice is less well facilitated for
women from different ethnic backgrounds in other areas of antenatal
screening,37 although several researchers have shown that both
preconception and antenatal screening is acceptable among the
population at risk.38–40 Ethnic diversity poses an extra challenge to
health care professionals to deliver equitable services.41 The discussion
in the Netherlands has focused primarily on equality in health care
and concerns over stigmatisation of certain groups in society;
however, the realisation that this may limit health care equity for
some has only surfaced in recent years.22 If we want to strive to
provide equitable healthcare services for all, it is important that health
professionals such as midwives and GPs are aware of these issues and
that discussions on equity, equality and access are part of (continuing)
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education programmes to enable them to provide women with
the care they need. Introduction of HbP-carrier screening should be
a part of meeting these needs, as proposed by the WHO.
Many countries have been hesitant about introducing ethnicity-
based HbP-carrier screening based on negative reports related
to discrimination and stigmatisation of groups at risk. In the past
SCD has been wrongly addressed as a ‘black disease’ and care for these
patients has been and very often still is shadowed by mistrust
and health care discrimination.19,42 Associating (carrier status of)
HbP with particular ethnic groups may undermine the success of a
possible screening programme. For such a programme to be
effective, equitable facilities for diagnosis and treatment should be
available.43 Moreover, the correct determination of ethnicity is
important, but it could also be possible that health professionals
and/or their patients find this difficult; they may need to be supported
by a tool to determine risk or universal screening should be
considered.15,44
We conclude that most practitioners are willing to offer screening
solely on the basis that ethnicity should become national policy,
however, not all. The fact that not all midwives and GPs answered
that they are not prepared to implement a national guideline for
HbP-carrier screening is unusual. The background of this result and a
more in depth analysis of the possible barriers for ethnicity-based
HbP-carrier screening warrant further investigation.
In developing and implementing new policy with regard to
HbP-carrier screening, debate among GPs and midwives should be
encouraged, articulating the voices of colleagues who already actively
offer HbP-carrier screening. Opinion leaders and professional orga-
nisations of primary health care professionals should be supported
by policy at national level when targeting GPs and midwives to
implement HbP-carrier screening.
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